Buy S-23 Capsules – Next LVL Muscle

Product Overview

S-23 Capsules provide a superior, brandless research chemical encapsulated at ≥98% purity for advanced laboratory work in analytical chemistry and selective receptor modulation studies. This format ensures accurate, dust-free handling as a reference standard for examining molecular affinities and structural characteristics in strictly in vitro environments. With comprehensive batch controls, S-23 Capsules equip qualified researchers for reproducible non-clinical investigations across diverse protocols.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.​

Chemical Identity & Classification

S-23 is designated by CAS number 1010396-29-8, securing its position in standardized chemical inventories for precise identification. The molecular formula C18H13ClF4N2O3 yields a molecular weight of 416.76 g/mol, delivering critical data for assay development and quantitative analysis. Synonyms encompass (2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-chloro-3-fluorophenoxy)-2-hydroxy-2-methylpropanamide, classifying it as a nonsteroidal synthetic analytical reagent and reference compound for androgen receptor research applications. This category aligns it with tools for in vitro binding and selectivity profiling by expert laboratory teams.

Chemical & Physical Characteristics

Within S-23 Capsules resides a white to off-white crystalline powder, protected by gelatin or vegetarian shells for contamination-free laboratory transfer and dosing. Solubility characteristics include high levels in DMF (20 mg/mL), DMSO (14 mg/mL), and ethanol (10 mg/mL), with lower rates in aqueous buffers, guiding reconstitution for chromatographic and spectrometric work. Notable properties feature a predicted density of 1.45 g/cm³, optical rotation [α]/D +20° (c=0.1, chloroform), and light/moisture sensitivity addressed by encapsulation, plus stability metrics supporting thermal evaluations up to decomposition thresholds. These traits enable consistent utility in HPLC purity checks, LC-MS identifications, and NMR structural confirmations, providing objective parameters for research documentation.

Purity & Analytical Verification

S-23 Capsules maintain ≥98% purity across batches, validated by High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), Nuclear Magnetic Resonance (NMR), and Gas Chromatography (GC) to profile impurities comprehensively. Quantitative assessments limit heavy metals to <5 ppm, residual solvents to ICH-compliant levels, and microbial burdens to non-detectable, fulfilling reference material specifications. Lot-specific Certificates of Analysis (COAs) include chromatograms, mass spectra, and purity declarations (typically >99% HPLC), supplied for laboratory accreditation and method transfer. This multi-tiered authentication underpins reliability in potency assays and long-term reference deployments.

Quality Control & Batch Integrity

S-23 production employs dedicated batch numbering for seamless traceability spanning synthesis, encapsulation, and release testing phases. In-line verifications cover content uniformity, capsule weight variation (<3%), and potency via validated HPLC, complemented by external lab confirmations for enantiomeric purity and degradation monitoring. Accelerated stability trials project 36-month viability under controlled storage, with archived retainers enabling retesting for multi-year projects. Detailed records—from vendor qualifications to cleanroom logs—facilitate audit readiness, while statistical process controls minimize deviations, assuring labs of material consistency for parallel experiments and cross-validation studies. This holistic QC elevates S-23 Capsules as a benchmark for research reproducibility.

Safety, Handling & Laboratory Precautions

Authorized personnel must process S-23 Capsules in equipped facilities, donning nitrile gloves, face shields, Tyvek suits, and powered air-purifying respirators inside laminar flow hoods or gloveboxes. Verify capsule wholeness pre-use; breaches demand immediate containment with vermiculite followed by solvent decontamination. SDS highlights GHS07 irritant status (H315/H319/H335), with eyewash stations mandatory and skin exposures prompting 15-minute irrigation. Disposal integrates into certified hazardous waste streams via autoclaving and incineration, barring unsupervised access and enforcing spill kits availability. Protocols prioritize enclosure to uphold laboratory safety margins exclusively.

Packaging, Labeling & Storage

S-23 Capsules deploy in opaque, desiccant-lined HDPE bottles or aluminized blisters with induction seals thwarting tampering and ingress. Labels integrate CAS 1010396-29-8, C18H13ClF4N2O3, ≥98% purity, lot/expiry codes, UN numbers for transport, and pictograms per GHS/DOT mandates. Maintain at -20°C shielded from light in nitrogen-purged containers, achieving >30-month integrity; thaw sealed at ambient prior to inventory. Segregated storage averts cross-contamination in climate-controlled repositories.

Intended Research Use & Market Positioning

S-23 Capsules suit analytical labs, SAR optimization in R&D, doping control forensics, and institutional androgen pathway dissections demanding encapsulated precision. They advance binding affinity mappings (AR Ki ~96 nM), tissue selectivity screens, and suppression dynamic models in cell-based reporters—all in vitro. Branded “Next LVL Muscle” tier, this generic ≥98% pure option economizes bulk screening versus patented formats, streamlining workflows in potency titrations and analog benchmarking. Essential for structural informatics, metabolic fate tracing, and modulator library curation in compliant scientific domains.

Ordering, Availability & Fulfillment

S-23 Capsules stock reliably on fortified eCommerce hubs with tokenization-secured payments spanning Visa to cryptocurrency for global access. Insulated, unmarked parcels ship via priority couriers with GPS tracking and duties prepaid, landing in 2-5 days domestically or 5-10 internationally. Custom quantities, digital COAs, and API integrations serve enterprise labs; concierge support navigates compliance docs and rush orders. Velocity fulfillment aligns with research cadences.

Legal & Regulatory Disclaimer

S-23 Capsules (CAS 1010396-29-8) distribute expressly for laboratory research only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Recipients affirm total accountability for regulatory conformity across jurisdictions; pre-purchase legal due diligence is imperative.